Surgical approach to pancreatic exocrine neoplasms.
Pancreatic exocrine neoplasms represent a wide spectrum of pathophysiologic entities that challenge us as surgeons. The workup and management of these lesions continue to evolve as we better understand their complex nature. In this review, we will explore the contemporary clinical management of pancreatic adenocarcinoma, acinar cell carcinoma, and cystic neoplasms of the pancreas. The pathogenesis and epidemiology of these tumors will also be examined.
Wargo
J A
JA
Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA. jwargo@partners.org
Warshaw
A L
AL
D000230:Adenocarcinoma / Q000601:surgery; D000465:Algorithms; D018267:Carcinoma, Acinar Cell / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003536:Cystadenocarcinoma / Q000601:surgery; D003537:Cystadenoma / Q000601:surgery; D003663:Decision Trees; D006801:Humans; D008279:Magnetic Resonance Imaging; D020360:Neoadjuvant Therapy / Q000379:methods; D009367:Neoplasm Staging; D046790:Pancreas, Exocrine / Q000601:surgery*; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D018714:Radiotherapy, Adjuvant; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome